loading
Schlusskurs vom Vortag:
$0.5958
Offen:
$0.5793
24-Stunden-Volumen:
821.58K
Relative Volume:
0.05
Marktkapitalisierung:
$22.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.36M
KGV:
-0.7326
EPS:
-0.7368
Netto-Cashflow:
-
1W Leistung:
-26.58%
1M Leistung:
+133.02%
6M Leistung:
-29.31%
1J Leistung:
-67.91%
1-Tages-Spanne:
Value
$0.53
$0.582
1-Wochen-Bereich:
Value
$0.5026
$0.91
52-Wochen-Spanne:
Value
$0.2027
$3.89

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Name
Firmenname
Calidi Biotherapeutics Inc
Name
Telefon
(858) 794-9600
Name
Adresse
4475 Executive Drive, Suite 200, San Diego
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CLDI's Discussions on Twitter

Vergleichen Sie CLDI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CLDI
Calidi Biotherapeutics Inc
0.5321 20.20M 0 -23.36M 0 -0.7368
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.08 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.13 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
388.30 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
661.28 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
293.06 32.46B 3.81B -644.79M -669.77M -6.24

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-22 Eingeleitet H.C. Wainwright Buy
2023-10-09 Eingeleitet Robert W. Baird Outperform

Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten

pulisher
09:02 AM

Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Batesville Daily Guard

09:02 AM
pulisher
Jul 31, 2025

What is Calidi Biotherapeutics Inc. company’s growth strategyStock Market Forecasts From AI Tools - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

Chart based analysis of Calidi Biotherapeutics Inc. trendsChart Driven High Reward Trading Setup Presented - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Live Scanner Shows Breakout on Calidi Biotherapeutics Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Calidi Biotherapeutics Stock Plunges 10.6% Despite FDA Fast Track Designation - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Is it too late to sell Calidi Biotherapeutics Inc.AI Screener Based Stock Summary Report - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

What risks could impact Calidi Biotherapeutics Inc. stock performanceFree Stock Screener With Smart Filters - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Candlestick signals on Calidi Biotherapeutics Inc. stock todayLong-Term Stock Growth Forecast Insights - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Calidi Biotherapeutics Receives FDA Fast Track Designation - GlobeNewswire

Jul 29, 2025
pulisher
Jul 29, 2025

Short Covering May Lift Calidi Biotherapeutics Inc. in Near TermShort Term High Yield Stock Tips for Active Traders - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Calidi Biotherapeutics Stock Soars 68% on FDA Fast Track Designation - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma - The Manila Times

Jul 29, 2025
pulisher
Jul 29, 2025

FDA grants fast track designation to Calidi’s CLD-201 for sarcoma - Investing.com Nigeria

Jul 29, 2025
pulisher
Jul 29, 2025

FDA Fast-Tracks Revolutionary Stem Cell-Viral Therapy for Aggressive Cancer Treatment - Stock Titan

Jul 29, 2025
pulisher
Jul 29, 2025

Is Calidi Biotherapeutics Inc. a Top Dividend Stock to Watch in 2025Early Entry Ideas with Momentum Potential - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Calidi Biotherapeutics Inc. Stock Support and Resistance Levels You Should KnowValue Investing Checklist with Entry Signals - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Why Calidi Biotherapeutics Inc. stock attracts strong analyst attentionMarket Ready Picks with Technical Support - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 02:14:07 - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split to Optimize Market Dynamics - citybuzz -

Jul 28, 2025
pulisher
Jul 28, 2025

Is Calidi Biotherapeutics Inc. stock overvalued or undervaluedPhenomenal wealth increase - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How to forecast Calidi Biotherapeutics Inc. trends using time seriesPrice Action Summary and Entry Strategy Guide - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How to interpret RSI for Calidi Biotherapeutics Inc. stockShort Term Opportunity Finder with Tools - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Does Calidi Biotherapeutics Inc. stock perform well during market downturnsRecord-setting profit potential - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why Did Calidi Biotherapeutics Stock Plunge 10.55%? - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Calidi Biotherapeutics Inc. in the next 12 monthsMaximize returns with strategic portfolio planning - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How does Calidi Biotherapeutics Inc. compare to its industry peersInvest confidently with professional guidance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Calidi Biotherapeutics Inc. stock compared to the marketHigh-yield market plays - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Calidi Biotherapeutics Inc. stock price move sharplyAccelerated wealth expansion - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Buy Signal for Calidi Biotherapeutics Inc. Stock Key Technical Indicators to WatchSmart Trading With Safety Margin - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Calidi announces reverse stock split, expected to begin trading on a 1-for-12 split adjusted basis - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

Calidi announces 1-for-12 reverse stock split - TipRanks

Jul 25, 2025
pulisher
Jul 25, 2025

Calidi Biotherapeutics' 1-for-12 Reverse Stock Split: Strategic Rebranding or a Desperate Lifeline? - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split to Enhance Market Appeal - Quiver Quantitative

Jul 25, 2025
pulisher
Jul 25, 2025

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025 - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

Calidi Biotech Plans Major 1:12 Reverse Split: What Shareholders Must Know Before August 5 - Stock Titan

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Calidi Biotherapeutics Inc. stockExplosive returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Calidi Biotherapeutics Inc. a good long term investmentMassive portfolio appreciation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Calidi Biotherapeutics Inc. stock overhyped or has real potentialTriple-digit returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Calidi Biotherapeutics Inc. stock priceRapid wealth creation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Should I buy Calidi Biotherapeutics Inc. stock before earningsExplosive portfolio gains - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Calidi Biotherapeutics Inc. Stock Analysis and ForecastMassive profits - PrintWeekIndia

Jul 24, 2025

Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$75.08
price up icon 0.12%
$36.88
price up icon 0.24%
$25.75
price down icon 1.73%
$107.09
price down icon 0.55%
$106.00
price down icon 1.41%
biotechnology ONC
$289.95
price down icon 3.55%
Kapitalisierung:     |  Volumen (24h):